|
|
|
|
|
10.11.25 - 22:33
|
LivePerson Announces Third Quarter 2025 Financial Results (PR Newswire)
|
|
|
-- Total Revenue of $60.2 million, above the high end of our guidance range -- -- Adjusted EBITDA above the high end of our guidance range -- NEW YORK, Nov. 10, 2025 /PRNewswire/ -- LivePerson, Inc. (NASDAQ: LPSN) ("LivePerson" the "Company", "we" or "us"), a leading provider of......
|
|
|
|
|
|
|
|
|
10.11.25 - 22:33
|
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight (GlobeNewswire EN)
|
|
|
TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets artificial intelligence (“AI”)-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, is pleased to announce that it has regained exclusive distribution rights for TULSA-PRO® in Canada from Knight Therapeutics Inc. (“Knight”)....
|
|
|
10.11.25 - 22:33
|
FSI OFFER TO ACQUIRE AN AGRICULTURE COMPANY DECLINED (GlobeNewswire EN)
|
|
|
TABER, ALBERTA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE-AMERICAN: FSI), is the developer and manufacturer of biodegradable polymers for oil extraction, detergent ingredients and water treatment as well as crop nutrient availability chemistry. Flexible Solutions also manufactures biodegradable and environmentally safe water and energy conservation technologies. In addition, FSI is increasing its presense in the food and nutrition supplement manufacturing markets. Today the Company announces an offer made to acquire an agriculture company was declined....
|
|
|
10.11.25 - 22:33
|
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2025 Financial Results on November 14, 2025 (GlobeNewswire EN)
|
|
|
FREDERICK, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the third quarter ended September 30, 2025, after the close of the financial markets on Friday, November 14, 2025, and will hold a conference call at 4:30 p.m. ET that day....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.11.25 - 22:30
|
Xtant Medical Reports Third Quarter 2025 Financial Results (PR Newswire)
|
|
|
Total Revenue of $33.3 Million Increased 19% Year-over-Year Delivers Positive Net Income, Adjusted EBITDA and Operating Cash Flow Reiterates FY25 Revenue Guidance of $131-$135 Million, Representing Growth of 11%-15% over FY24 Previously Announced Sale of Certain Hardware Assets and OUS......
|
|
|
|
|
|
|
|
|
|